ECCO 17 - ESMO 38 - ESTRO 32
ADVANCE PROGRAMME
32
Debate: This House Believes That
the EU Clinical Trials Directive has
Harmed European Clinical Studies
›
17:00 - 18:00
Moderator: J.S. de Bono (United Kingdom)
Speaker in favour: F. Meunier (Belgium)
Speaker against: C. Tomino (Italy)
Seconder in favour: P.G. Casali (Italy)
Seconder against: A. Yver (USA)
Questions and answers with final vote
Sarcoma: Soft Tissue
and Bone
Monday 30 September 2013
———
Special Session: Medical Treatment
of GIST
n
13:15 - 14:15
Chair: P.G. Casali (Italy)
How to order the many different
medical treatments
Speaker: P. Reichardt (Germany)
Adjuvant treatment: to whom, how
much and for how long?
Speaker: H. Joensuu (Finland)
How canmolecular biology guide future
research?
Speaker: J. Martin-Broto (Spain)
Discussion and Roundup
———
Scientific Symposium: Innovative
Treatment Modalities in Sarcomas
n
14:45 - 16:45
Chair: P.G. Casali (Italy)
Chair: B. O'Sullivan (Canada)
Introduction
Speaker: P.G. Casali (Italy)
Proton or carbon ion therapy for
chondrosarcomas and chordomas?
Speaker: J. Debus (Germany)
MDM2 and CDK4 as a therapeutic
target in sarcomas
Speaker: J.Y. Blay (France)
Targeted treatment of Ewing sarcomas:
Current status
Speaker: B. Hassan (United Kingdom)
Denosumab in giant cell tumours: When
and for how long?
Speaker: S. Ferrari (Italy)
Concluding Remarks
Speaker: B. O'Sullivan (Canada)
———
Debate: This House Believes That
Metastasis of Sarcoma Should be
Removed if Complete Response is
Achievable
n
17:00 - 18:00
Moderator: F. Van Coevorden (The Netherlands)
Speaker in favour: P. Hohenberger (Germany)
Speaker against: A. Gronchi (Italy)
Seconder in favour: P. Rutkowski (Poland)
Seconder against: A. Le Cesne (France)
Questions and answers with final vote
Tuesday 30 September 2013
———
Teaching Lecture: Role of Expert
Centres in theManagement of
Sarcomas
n
8:00 - 8:45
Speaker: I. Judson (United Kingdom)
———
Special Session: Retroperitoneal
Sarcomas
n
11:30 - 12:30
Chair: P. Hohenberger (Germany)
Surgical aspects
Speaker: S. Bonvalot (France)
The role of radiotherapy
Speaker: R. Haas (The Netherlands)
The role of chemotherapy
Speaker: M. Montemurro (Switzerland)
Discussion and Roundup
Surgical Oncology
Saturday 28 September 2013
———
Teaching Lecture: Oncoplastic
Surgery – Standard of Care
v
8:00 - 8:45
Speaker: A.D. Baildam (United Kingdom)
———
Special Session: Minimally Invasive
Cancer Surgery: What is the
Benefit?
v
14:15 - 15:15
Chair: S. Gonzalez-Moreno (Spain)
Robotic surgery
Speaker: D. Jayne (United Kingdom)
NOTES
Speaker: R.A. Cahill (Ireland)
Laparoscopic surgery
Speaker: M. A. Cuesta (The Netherlands)
Discussion and Roundup
Sunday 29 September 2013
———
Teaching Lecture: Surgical
Management of NET Liver
Metastases
v
8:00 - 8:45
Speaker: P. Hellman (Sweden)
———
Special Session: Centralisation
of Complex Cancer Surgery: Do
Outcomes Improve?
v
13:15 - 14:15
Chair: G. Poston (United Kingdom)
US perspective
Speaker: M. Brennan (USA)
Swedish perspective
Speaker: P. Naredi (Sweden)
Dutch perspective
Speaker: M. Wouters (The Netherlands)
Discussion and Roundup
———
Scientific Symposium: Minimal
Metastatic Pancreatic Cancer: Is it
a Surgical Disease?
v
14:45 - 16:45
Chair: V. Heinemann (Germany)
Chair: D.J. Gouma (The Netherlands)
Introduction
Speaker: V. Heinemann (Germany)
Key criteria in imaging
Speaker: N. Albiin (Sweden)
Neoadjuvant therapy in estimating
disease aggressiveness?
Speaker: D. Cunningham (United Kingdom)
Value of synchronous resection?
Speaker: M.W. Büchler (Switzerland)
1...,22,23,24,25,26,27,28,29,30,31 33,34,35,36,37,38,39,40,41,42,...60